Therapeutic targets for inflammatory bowel disease: proteome-wide Mendelian randomization and colocalization analyses

Chen, J; Xu, FZ; Ruan, XX; Sun, J; Zhang, Y; Zhang, H; Zhao, JH; Zheng, J; Larsson, SC; Wang, XY; Li, X; Yuan, S

Li, X (通讯作者),Zhejiang Univ, Sch Publ Hlth, Sch Med, Dept Big Data Hlth Sci, Hangzhou, Zhejiang, Peoples R China.;Li, X (通讯作者),Zhejiang Univ, Affiliated Hosp 2, Sch Med, Hangzhou, Zhejiang, Peoples R China.;Wang, XY (通讯作者),Cent South Univ, Xiangya Hosp 3, Dept Gastroenterol, Changsha, Peoples R China.;Yuan, S (通讯作者),Karolinska Inst, Inst Environm Med, Unit Cardiovasc & Nutr Epidemiol, Stockholm, Sweden.

EBIOMEDICINE, 2023; 89 ():

Abstract

Background Identifying new drug targets for inflammatory bowel disease (IBD) is urgently needed. The proteome is a major source of therapeutic targets......

Full Text Link